LiveCare Adds Texas & Ohio to Its State Expansion Initiative

VENICE, Florida—LiveCare, Inc. (OTC:LVCE), a telehealth company, announced the expansion of its services into Texas and Ohio, a key development in its state expansion initiative. This expansion, increasing LiveCare’s reach, has been conducted in conjunction with Bikham Healthcare, a multinational provider of health care support services and solutions specializing in revenue cycle management, medical billing and credentialing

Beginning in early September 2023, LiveCare has actively pursued extending its services beyond its Florida headquarters. The company has made rapid strides in the credentialing of health professionals in new states, particularly following the rollback of emergency measures earlier in 2023. The addition of Texas and Ohio, where nearly 4 million individuals are affected by diabetes, complements the existing Florida base of 2.1 million, effectively tripling LiveCare’s potential patient pool.

This expansion is further bolstered by LiveCare’s recent approval for Medicaid billing in Florida. This development opens up market opportunities to more than 5 million Medicaid-insured individuals in Florida, increasing LiveCare’s potential client base. This expansion includes existing insurance credentialing with Florida Blue, WellCare and Medicare.

“The expansion into Texas and Ohio, in collaboration with Bikham Healthcare, is a major milestone for our team,” said Max Rockwell, CEO of LiveCare. “It not only triples our potential patient pool but also aligns with our goal to provide accessible, high-quality health care. Our recent Medicaid billing approval in Florida, along with our partnerships with major insurers, further extends our reach to a wider audience.”

LiveCare’s focused expansion strategy, particularly in addressing the health care needs of those with diabetes, is underscored by its telemedicine solutions and commitment to expanding access to underserved populations, the company said. Upon the completion of phase one, LiveCare anticipates being licensed in Florida, New York, Texas Ohio, Michigan, Illinois, California, North Carolina, South Carolina and Georgia, covering more than half of the U.S. population.